Martin Nutraceuticals is Pleased to Announce Agreement with Novolypharma in Spain.RENO, Nev. -- Martin Nutraceuticals Inc. (PINKSHEETS:MNCL MNCL Maintenance Non-Computing (Module) Load ) is pleased to announce it is now in the final stages of an agreement with Novolypharma, out of Madrid, Spain. The agreement will not only provide for the production of its flagship products, but will also allow Martin Nutraceuticals to acquire the distribution rights for various Novolypharma products. Novolypharma is a nutraceutical laboratory with the most advanced level of technology currently available in the nutraceutical manufacturing field, allowing it to conform to FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. (Pharmaceutical) Standards. Novolypharma is majority owned by X Consul Group Company, is a very well respected conglomerate in the nutraceutical marketplace, which includes companies such as CIMA 27, Ydosis and Kapal Consulting. X Consul Global Company maintains the rights for the worldwide licensing of Novolypharma products, which includes the CGY cGy centigray. 25 plant extract that promotes prostate and sexual health substantiated by scientific research conducted by the Montpelier University of France The University of France (French: Université de France; originally the Imperial University of France) was a highly centralized educational state organization founded by Napoleon I in 1808 and given authority not only over the and the University of Seoul Not to be confused with Seoul National University. The University of Seoul is a public university operated by the municipal government of Seoul Metropolitan City, South Korea. The campus stands in Jeonnong-dong, Dongdaemun-gu. of South Korea. "We are very excited about finalizing this agreement with Novolypharma and X Consul Global," states Mr. Harvey Panesar, President of Martin Nutraceuticals Inc., "this is a great boost for our current products as well the products that are being developed. Not only will we be with a FDA approved laboratory, we will also have access to many of Novolypharma's products, allowing us to maintain our quality of products and expand our product line. Getting ready for our US launch of the Infomercial and the products, we felt strongly about aligning ourselves with a GMP GMP (guanosine monophosphate): see guanine. and FDA approved lab, which is what Novolypharma provides us." About Martin Nutraceuticals Inc. Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control. Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin fibrin: see blood clotting. in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion